US FDA approves first 'digital pill'
The U.S. Food and Drug Administration (FDA) on Monday approved a “digital pill” for the first time ever, but a consumer advocate group said Tuesday its users should be wary, APA reports quoting AA.
The pill is equipped with a tiny sensor that transmits data about whether the patient had taken the pill or not.
Though the move has been lauded as a milestone for the infant field of digital medicine, some are raising concerns about privacy and costs.
Named Abilify MyCite, the medication is produced by Otsuka Pharmaceutical based in Japan and is outfitted with a sensor built by a company called Proteus Digital Health. Abilify, the drug, is an antipsychotic medicine used to treat mental illnesses like bipolar disorder and schizophrenia.
The sensor, about the size of a grain of sand, is activated when it comes into contact with stomach acid. It transmits data to a patch that, in turn, can send information to a smartphone app that lets family members or caretakers know that a patient took the medication.
“Being able to track ingestion of medications prescribed for mental illness may be useful for some patients,” Mitchell Mathis, director of the Division of Psychiatry Products in the FDA’s Center for Drug Evaluation and Research, said in a statement Monday.
“The FDA supports the development and use of new technology in prescription drugs and is committed to working with companies to understand how technology might benefit patients and prescribers.”
The creators of Abilify MyCite believe it will lead the way toward other medications solving the issue of nonadherence, i.e., when patients do not follow the treatment instructions of their doctors.
“The time is right for the category of digital medicines to be available to appropriate patients with serious mental illness,” Proteus CEO Andrew Thompson said in a statement released Tuesday.
“Consumers already manage important tasks like banking, shopping and communicating with friends and family by using their smartphones as they go about their daily lives.”
The ability to track someone’s medicine intake, however, is unnerving some digital privacy advocates like the Electronic Frontier Foundation.
“Before you swallow one of these — just like with any other device — make sure you know what sensitive medical data is being collected about you and how it's being used and stored,” the group said Tuesday on Twitter
Related news releases
- 18.03.20181 person dead in shooting at Southern California mall, authorities say
- 18.03.2018Florida officials knew about bridge crack
- 17.03.2018Trump, South Korea's Moon discuss engagement with North
- 16.03.2018US: At least 6 dead in Florida bridge collapse
- 16.03.2018At least four dead in pedestrian bridge collapse at university in Miami - UPDATED
- 16.03.2018Nike brand president resigns; company probes workplace complaints
- 16.03.2018Colombia resumes peace talks with ELN rebels
- 16.03.2018Facebook Lite to launch in developed countries, including US
- 16.03.2018Broadcom tops revenue, profit on demand from smartphone makers
- 16.03.2018Several reported dead after pedestrian bridge collapses in Miami
- 15.03.2018Mueller subpoenas Trump organization, demands Russia-related docs
- 15.03.2018Explosion hits chemical plant in Texas, building ablaze - UPDATED
- 15.03.2018Former Trump campaign manager Manafort files to dismiss charges
- 15.03.2018U.S. Ambassador Haley tells U.N. Russia responsible for chemical attack
- 15.03.2018Trump taps commentator Kudlow for top economic adviser
- 15.03.2018US students rally nationwide against gun violence
- 15.03.2018Russian UN Envoy: 'Unacceptable' for UK to accuse Moscow of nerve agent attack
- 15.03.2018At least six die in Bolivia prison uprising
- 14.03.2018Three arrested, charged in US mosque bombing
- 13.03.2018White House fires top Tillerson aide after comments on Boss' firing
- 13.03.2018US defense secretary backs Afghan overtures to Taliban
- 13.03.2018Trump: Tillerson and I "disagreed on things" like the Iran deal
- 13.03.2018Trump sacks Rex Tillerson as state secretary
- 13.03.2018White House expects North Korea summit to happen despite Pyongyang's silence
- 13.03.2018US: House Republicans find no Trump-Russia collusion
- 13.03.2018U.S. may lift travel ban on 'important partner' Chad, Tillerson says
- 13.03.2018U.N. blames Honduras security forces for killing electoral protesters
- 12.03.2018U.S. warns if Security Council doesn't act on Syria, it will
- 12.03.2018Tillerson says several steps needed for U.S. talks with North Korea
- 11.03.2018Trump says North Korea talks could fail or bring 'greatest deal'
- 10.03.2018US Secretary of State Tillerson Ill, Cancels Africa Tour Events
- 10.03.2018Trump to rally for endangered Republican in Pennsylvania
- 10.03.20183 hostages and gunman dead at California veterans' home
- 10.03.2018U.S. seeks 'concrete actions' from North Korea before talks
- 10.03.2018UN welcomes planned Trump-Kim meeting
- 08.03.2018Alabama student dies in accidental school shooting: officials
- 08.03.2018U.N. urges Syria to ensure truce for Ghouta aid convoy on Thursday
- 07.03.2018UN secretary-general: Gender inequality and discrimination against women harms us all
- 07.03.2018U.S. President's top economic adviser stepping down
- 07.03.2018State Dept sanctions DPRK for using agent VX to kill Kim Jong Un’s half-brother
- 15.11.2017U.S. security officials arrive in Israel to discuss Syria agreement
- 15.11.2017Planned talks between Venezuelan opposition, government will not take place
- 16.11.2017US Democrats enter new articles to impeach Trump
- 15.11.2017Death toll as a result of a gunman in California fired at school reached - UPDATED
- 15.11.2017De Mistura: Putin, Trump create qualitatively new situation in Syrian settlement
- 14.11.2017At least 3 dead in California school shooting, shooter killed by police